Arabinogalactan For Hepatitis Drug Delivery

We have collected information about Arabinogalactan For Hepatitis Drug Delivery for you. Follow the links to find out details on Arabinogalactan For Hepatitis Drug Delivery.


Arabinogalactan for Hepatic Drug Delivery Bioconjugate ...

    https://pubs.acs.org/doi/abs/10.1021/bc00030a010
    Arabinogalactan (9kDa)-9-β-D-Arabinofuranosyladenine-5′-Monophosphate, A Novel Liver-Targeted Conjugate that Selectively Inhibits Hepatitis B virus Replication in Vitro. Antiviral Chemistry and Chemotherapy 1997 , 8 (6) , 529-536.Author: Ernest V. Groman, Philip M. Enriquez, Chu Jung, Lee Josephson

Larch arabinogalactan for hepatic drug delivery: isolation ...

    https://www.sciencedirect.com/science/article/pii/0008621595002412
    A lower molecular weight form of arabinogalactan offers several potential advantages with respect to its use in targeted drug delivery. A 9 kDa arabinogalactan would have selected advantages over AG(37 kDa) in both subcutaneous and intramuscular administration routes due to enhanced diffusion resulting from its lower molecular weight [31].Author: James H. Prescott, Philip Enriquez, Chu Jung, Edward Menz, Ernest V. Groman

Larch arabinogalactan for hepatic drug delivery: isolation ...

    https://www.ncbi.nlm.nih.gov/pubmed/8536264
    Nov 30, 1995 · Purified arabinogalactan [AG(37 kDa)] from Larix occidentalis is composed of repeating units of similar molecular weight and composition. A 9 kDa arabinogalactan [AG(9 kDa)] has been obtained in high yield from AG(37 kDa) either by autoclaving at 121 degrees C or by exposure to alkaline solution in the presence of sodium borohydride.Author: James H. Prescott, Philip Enriquez, Chu Jung, Edward Menz, Ernest V. Groman

Dr. Peter D'Adamo / Larch Arabinogalactan is a Novel ...

    https://www.dadamo.com/txt/index.pl?3004
    The 9 kDa and 37 kDa fractions from larch arabinogalactan are apparently the best candidates for use in hepatocyte directed drug delivery (34). Larch arabinogalactan improves liver contrast enhancement, and has a significant effect on hepatic lesion detection as assessed by CNR (35).

A Review of Larch Arabinogalactans Clinical Education

    https://www.clinicaleducation.org/resources/reviews/a-review-of-larch-arabinogalactans/
    In the case of larch arabinogalactan, molecular weights of the two major fractions are 16,000 and 100,000, perhaps accounting for its wide range of therapeutic properties. L.A. is approved by the U.S. Food and Drug Administration (FDA) as a source of dietary fibre, but also has potential therapeutic benefits as an immune stimulating agent and cancer protocol adjunct.

Larch arabinogalactan for hepatic drug delivery ... - DeepDyve

    https://www.deepdyve.com/lp/elsevier/larch-arabinogalactan-for-hepatic-drug-delivery-isolation-and-gsOhr0WetV
    Larch arabinogalactan for hepatic drug delivery: isolation and characterization of a 9 kDa arabinogalactan fragment Larch arabinogalactan for hepatic drug delivery: isolation and characterization of a 9 kDa...

Larch Arabinogalactans Monograph Semantic Scholar

    https://www.semanticscholar.org/paper/Larch-Arabinogalactans-Monograph-Arabinogalactan/989d4486602f7edae8c3c7fe9ecfeedcaaa95a96
    Alternative Medicine Review Volume 5, Number 5 2000 Page 463 Larch Arabinogalactan Introduction Larch arabinogalactan is a polysaccharide powder derived from the wood of the larch tree (Larix species) and comprised of approximately 98 percent arabinogalactan. Arabinogalactans are found in a variety of plants but are more abundant in the Larix genus, primarily Larix occidentalis (Western Larch ...

Larch Arabinogalactan: Health Benefits, Uses, Side Effects ...

    https://www.rxlist.com/larch_arabinogalactan/supplements.htm
    Larch arabinogalactan is used for infections, including the common cold, flu, H1N1 (swine) flu, ear infections in children, and HIV/AIDS. It is also used to treat liver cancer , as well as a brain condition caused by liver damage ( hepatic encephalopathy ).

Therapy of Chronic Hepatitis C in the Era of ...

    http://www.eurekaselect.com/146516/article
    Therapy of Chronic Hepatitis C in the Era of Nanotechnology: Drug Delivery Systems and Liver Targeting Author(s): Maria Lujan Cuestas . Institute of Microbiology and Medical Parasitology, University of Buenos Aires-National Science Research Council (IMPaM, UBA-CONICET), Ciudad Autonoma de Buenos Aires,, ArgentinaAuthor: Maria Lujan Cuestas

Searching for Arabinogalactan For Hepatitis Drug Delivery?

You can just click the links above. The data is collected for you.

Related Delivery Info